Last reviewed · How we verify

NCT04035213

Sleep, the Never-ending Quest of College Students

Completed NA Last updated 28 November 2023
What this trial tests

NA trial testing Behavior of Sleep Course in Sleep in 146 participants. Completed in 1 August 2023.

Timeline
19 August 2019
Primary endpoint
1 December 2021
1 August 2023

Quick facts

Lead sponsorUniversity of Houston
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment146
Start date19 August 2019
Primary completion1 December 2021
Estimated completion1 August 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Houston

Who can join

18 and older, any sex, with Sleep or Sleep Disturbance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate whether undergraduate students completing a course focused entirely on sleep at a major urban university evidence positive changes in their sleep patterns compared to students completing a similar-level course (without any discussion of sleep) in the same department (Psychology) at the same university (UH). Potential changes in sleep patterns across the semester will be examined as well as whether putative changes in sleep can be linked with academic and mental health outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep

Currently open trials in the same condition.

Other University of Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04035213.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing